维持剂量

  • 网络Maintenance dose
维持剂量维持剂量
  1. 被安排给予氯吡格雷的患者,在PCI前的负载量为300mg,之后的维持剂量为每天75mg。

    Those assigned to clopidogrel received a300-mg loading dose before PCI , followed by a maintenance dose of75 mg daily .

  2. 如何用第3、第4日的INR预测维持剂量需评估。

    How the INR on day 3 and day 4 can be used to predict the maintenance dose needs to be evaluated .

  3. PCIA选择负荷剂量+维持剂量+PCIA给药模式(持续注射2ml/h,PCA剂量0.5ml/15min)。

    The model of administration was loading dose plus maintaining dose subjected to PCIA ( 2 ml / h , 0.5 ml / 15 min ) .

  4. 比较拉莫三嗪(LTG)与不同AEDs配伍的效果,与安全性及LTG常用维持剂量。

    We assessed not only the efficacy and safety of coadministration of LTG and different AEDs , but also the usual maintenance dose of LTG .

  5. 结论CVA患者吸入糖皮质激素(布地奈得)适宜的治疗剂量为400μg/d,而维持剂量为200μg/d。

    Conclusions The fitting treatment doses for CVA patients who inhale the corticosteroids ( budesonide ) is 400 μ g / d while the fitting maintenance doses is 200 μ g / d.

  6. 结果在相似的初始剂量下,肝炎病毒携带者组FK506血药浓度明显高于非携带者组,而且术后3个月及半年FK506维持剂量又明显低于非携带者组;

    Results Under the similar initial dosages , blood concentrations of FK506 in HV group were significantly higher than in non-HV group , but maintenance dosages of FK506 in HV group were markedly lower 3 months or 6 months after renal transplantation than in non-HV group .

  7. 对照组口服抗痉挛药氯苯氨丁酸,先3次/d,5mg/次口服,以后每隔7d每日增加5mg,至痉挛明显减轻时的剂量即为维持剂量。

    Patients in control group were treated with anti-spasm drug Baclofen orally , firstly three times a day with 5 mg every time orally and later every 8 days 5 mg was added a day , till the dosage when the spasm significantly relieved , that was the maintenance dosage .

  8. 根据单剂量给药参数计算出多剂量给药参数:τ为12h,D为0.1mL/kg,D(维持剂量)为0.08mL/kg。

    According to kinetic parameters of single dose , the multiple dose parameters were caculated : τ was 12 h , D ( priming dose ) was 0.1 mL / kg BW , D ( maintaining dose ) was 0.08 mL / kg BW .

  9. 维持剂量的药物治疗是安全进行康复治疗的基本保证。

    Medicine treatment with maintenance dosage is the basic grantee of the safe rehabilitation .

  10. 每月维持剂量可以注射在三角肌或臀肌。

    Monthly maintenance doses can be administered in either the deltoid or gluteal muscle .

  11. 此后维持剂量恒定,治疗6,10个月分别用联合帕金森病量表进行疗效评定。

    The curative effects were evaluated with UPDRS at 6 and 10 months after treatment .

  12. 分别予以不同剂量的咪达唑仑镇静,记录其维持剂量、维持时间以及不良反应的发生。

    They were given two different doses of midazolam to make sedation . The maintenance dose , the maintenance time and the untoward reaction were recorded .

  13. 为了控制症状,这些患者服用过很多哮喘药物,同时也口服维持剂量的皮质类固醇。

    These are people who are already on a lot of asthma medications and are also taking oral corticosteroids on a maintenance basis to try to control the symptoms they 're having .

  14. 如果对氯吡格雷抵抗的患者增加药物的维持剂量可以明显改善氯吡格雷的抗血小板作用,降低氯吡格雷抵抗的发生率,为一有效的防治氯吡格雷抵抗的方法。

    Increasing the dose of clopidogrel will improve the antiplatelet effect , degrade the prevalence of clopidogrel resistance , so , it is an effective method that can prevent and cure clopidogrel resistance .

  15. 具体措施有:①药物康复:给予肌注长效制剂或口服维持剂量的抗精神病药物,用药剂量折合成氯丙嗪效价为(238±9.67)mg/d。

    Concrete measures : 1 Drug rehabilitation : The patients were treated with intramuscular injection of ultralente agent or oral antipsychotic drugs , and the dosage equal to ( 238 ± 9.67 ) mg per day ( chloropromazine ) .

  16. 此外,直到最近,医学院还是教学生只能短暂使用麻醉剂,而且应该维持低剂量。

    Also , until recently medical schools taught that narcotics should be used only briefly at low doses .

  17. 方法采用1∶1对照回顾前瞻性方法,将Graves病病人分为沿海组和内陆对照组,观察两组Graves病首次缓解时间、维持期ATD剂量、1年反复率等。

    Methods Using 1 ∶ 1 retrospective and prospective methods , patients with Graves disease were divided into Coastal Group and Inland Group .

  18. 经逐步多元回归分析,影响服药依从性的主要因素为:家庭人际关系、维持治疗药物剂量、维持治疗时间、慢性精神病病人标准化精神症状量表评分。

    Stepwise multifactorial regression analysis revealed the major factors related to compliance were as follows : interpersonal relationship within family , maintenance antipsychotic dosage , duration of maintenance treatment and scores in chronic schizophrenics standardized psychiatric symptom scale .

  19. 71.6%认为维持治疗的最佳剂量是40-59mg.d-1;

    71.6 % thought the ideal dose for MMT was 40-59 mg · d-1 ;

  20. 由普通片剂改用口腔崩解片时建议病人维持使用原处方剂量。

    Patients should be advised to keep their same prescribed dose when switching from tablets to the new ODT formulation .